“The Overexpression of ABCG2 Reduces the Efficacy of Volasertib (BI 6727) and GSK641364 in Human S1-M1-80 Colon Carcinoma Cells”. Journal of Cancer Research Updates, vol. 3, no. 2, Apr. 2014, pp.  108-116, https://doi.org/10.6000/1929-2279.2014.03.02.5.